Official SEC submissions

Eloxx Pharmaceuticals SEC Filings

Direct answer

Eloxx Pharmaceuticals's latest SEC filing is S-1.

It was filed on September 11, 2026, and 40 recent filings are available.
Each row links directly to the SEC document and filing index.
Official SEC EDGAR submissions

Get free Eloxx Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

S-1

Registration statement

Filed:

S-1

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

10-Q

Periodic report

Filed:

Report date:

10-Q

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

Open SEC documentView filing index

S-1/A

Registration statement

Filed:

S-1/A

Open SEC documentView filing index

S-1/A

Registration statement

Filed:

S-1/A

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

OWNERSHIP DOCUMENT

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

4

Open SEC documentView filing index

S-1

Registration statement

Filed:

S-1

Open SEC documentView filing index

10-Q

Periodic report

Filed:

Report date:

10-Q

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

10-K

Periodic report

Filed:

Report date:

10-K

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

FORM 8-K

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

OWNERSHIP DOCUMENT

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

OWNERSHIP DOCUMENT

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

OWNERSHIP DOCUMENT

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

OWNERSHIP DOCUMENT

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

OWNERSHIP DOCUMENT

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

OWNERSHIP DOCUMENT

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

OWNERSHIP DOCUMENT

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

FORM 8-K

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

OWNERSHIP DOCUMENT

Open SEC documentView filing index

SC 13D/A

Ownership report

Filed:

FORM SC 13D/A

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

FORM 8-K

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

FORM 8-K

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

FORM 8-K

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

OWNERSHIP DOCUMENT

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

OWNERSHIP DOCUMENT

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

OWNERSHIP DOCUMENT

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

OWNERSHIP DOCUMENT

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

FORM 8-K

Open SEC documentView filing index

Verified data

Recent filing categories
5
Recent filings
40
SEC CIK
0001035354
Latest filing date
September 11, 2026

Explore related company data

View the Eloxx Pharmaceuticals company profileView Eloxx Pharmaceuticals annual financials